NO20014889D0 - Fremgangsmåte for fremstilling av medisinske midler - Google Patents
Fremgangsmåte for fremstilling av medisinske midlerInfo
- Publication number
- NO20014889D0 NO20014889D0 NO20014889A NO20014889A NO20014889D0 NO 20014889 D0 NO20014889 D0 NO 20014889D0 NO 20014889 A NO20014889 A NO 20014889A NO 20014889 A NO20014889 A NO 20014889A NO 20014889 D0 NO20014889 D0 NO 20014889D0
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- medical agents
- medical
- agents
- relates
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic System
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0803—Compounds with Si-C or Si-Si linkages
- C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Catalysts (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9901340A SE9901340D0 (sv) | 1999-04-15 | 1999-04-15 | Novel process |
PCT/SE2000/000713 WO2000063175A2 (en) | 1999-04-15 | 2000-04-14 | Novel process |
Publications (3)
Publication Number | Publication Date |
---|---|
NO20014889L NO20014889L (no) | 2001-10-08 |
NO20014889D0 true NO20014889D0 (no) | 2001-10-08 |
NO320810B1 NO320810B1 (no) | 2006-01-30 |
Family
ID=20415222
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20014889A NO320810B1 (no) | 1999-04-15 | 2001-10-08 | Fremgangsmate for fremstilling av forbindelser og forbindelsene (S)-1-fenyl-2-(2-pyridyl)etanamin og (S)-fenyl-2-(2-pyridyl)etanamin (S)-malatsalt. |
Country Status (18)
Country | Link |
---|---|
US (1) | US6518432B1 (no) |
EP (1) | EP1492769B1 (no) |
JP (1) | JP4676064B2 (no) |
KR (1) | KR100663811B1 (no) |
CN (1) | CN1138759C (no) |
AT (1) | ATE333444T1 (no) |
AU (1) | AU773962B2 (no) |
BR (1) | BR0009795B1 (no) |
CA (1) | CA2367410C (no) |
DE (1) | DE60029493T2 (no) |
ES (1) | ES2267526T3 (no) |
IL (2) | IL145585A0 (no) |
NO (1) | NO320810B1 (no) |
NZ (1) | NZ514586A (no) |
SE (1) | SE9901340D0 (no) |
TW (1) | TWI248433B (no) |
WO (1) | WO2000063175A2 (no) |
ZA (1) | ZA200108374B (no) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2011006680A (es) * | 2008-12-24 | 2011-07-12 | Astrazeneca Ab | Compuestos etanaminicos y su uso para tratar la depresion. |
CN105683180B (zh) | 2013-11-05 | 2020-01-21 | 阿斯利康(瑞典)有限公司 | Nmda拮抗剂前药 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9320273D0 (en) * | 1993-04-01 | 1993-11-17 | Fisons Corp | Compound useful in therapy |
US5455259A (en) * | 1987-02-06 | 1995-10-03 | Fisons Corporation | Compounds for the treatment of neurodegenerative disorders |
PT612314E (pt) * | 1991-10-30 | 2000-06-30 | Astra Ab | Derivados de etilamina 2-heterociclicos e seu uso como produtos farmaceuticos |
DE69317411T2 (de) | 1992-04-03 | 1998-07-30 | Astra Ab | Enantiomere 1-phenyl-2-(2-pyridinyl)ethylamin für die behandlung neurodegenerativer störungen |
-
1999
- 1999-04-15 SE SE9901340A patent/SE9901340D0/xx unknown
-
2000
- 2000-04-05 TW TW089106214A patent/TWI248433B/zh not_active IP Right Cessation
- 2000-04-14 US US09/555,050 patent/US6518432B1/en not_active Expired - Lifetime
- 2000-04-14 NZ NZ514586A patent/NZ514586A/en not_active IP Right Cessation
- 2000-04-14 EP EP00925816A patent/EP1492769B1/en not_active Expired - Lifetime
- 2000-04-14 BR BRPI0009795-0A patent/BR0009795B1/pt not_active IP Right Cessation
- 2000-04-14 ES ES00925816T patent/ES2267526T3/es not_active Expired - Lifetime
- 2000-04-14 JP JP2000612269A patent/JP4676064B2/ja not_active Expired - Fee Related
- 2000-04-14 AU AU44447/00A patent/AU773962B2/en not_active Ceased
- 2000-04-14 CA CA002367410A patent/CA2367410C/en not_active Expired - Fee Related
- 2000-04-14 WO PCT/SE2000/000713 patent/WO2000063175A2/en active IP Right Grant
- 2000-04-14 AT AT00925816T patent/ATE333444T1/de not_active IP Right Cessation
- 2000-04-14 DE DE60029493T patent/DE60029493T2/de not_active Expired - Lifetime
- 2000-04-14 CN CNB00806198XA patent/CN1138759C/zh not_active Expired - Fee Related
- 2000-04-14 KR KR1020017013069A patent/KR100663811B1/ko not_active IP Right Cessation
- 2000-04-14 IL IL14558500A patent/IL145585A0/xx active IP Right Grant
-
2001
- 2001-09-24 IL IL145585A patent/IL145585A/en not_active IP Right Cessation
- 2001-10-08 NO NO20014889A patent/NO320810B1/no not_active IP Right Cessation
- 2001-10-11 ZA ZA200108374A patent/ZA200108374B/en unknown
Also Published As
Publication number | Publication date |
---|---|
NO320810B1 (no) | 2006-01-30 |
CA2367410C (en) | 2009-08-11 |
ZA200108374B (en) | 2003-08-06 |
NZ514586A (en) | 2003-09-26 |
KR100663811B1 (ko) | 2007-01-03 |
SE9901340D0 (sv) | 1999-04-15 |
BR0009795B1 (pt) | 2011-12-27 |
NO20014889L (no) | 2001-10-08 |
ES2267526T3 (es) | 2007-03-16 |
ATE333444T1 (de) | 2006-08-15 |
JP2003524625A (ja) | 2003-08-19 |
EP1492769B1 (en) | 2006-07-19 |
BR0009795A (pt) | 2002-01-08 |
IL145585A (en) | 2006-12-31 |
EP1492769A2 (en) | 2005-01-05 |
CA2367410A1 (en) | 2000-10-26 |
WO2000063175A3 (en) | 2004-11-11 |
DE60029493D1 (de) | 2006-08-31 |
WO2000063175A2 (en) | 2000-10-26 |
KR20010113799A (ko) | 2001-12-28 |
JP4676064B2 (ja) | 2011-04-27 |
TWI248433B (en) | 2006-02-01 |
AU4444700A (en) | 2000-11-02 |
AU773962B2 (en) | 2004-06-10 |
IL145585A0 (en) | 2002-11-10 |
CN1138759C (zh) | 2004-02-18 |
CN1370145A (zh) | 2002-09-18 |
US6518432B1 (en) | 2003-02-11 |
DE60029493T2 (de) | 2007-01-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB9914486D0 (en) | Medicaments | |
TR200200579T2 (tr) | Amino-tirazolpiridin türevleri. | |
ATE339406T1 (de) | Chinazoline verbindungen als heilmittel | |
RS50140B (sr) | Postupak za dobijanje perkihinina i njegova upotreba | |
NZ516347A (en) | Indanyl-substituted benzenecarboxamides, process for their preparation, their use as a medicament and pharmaceutical formulations containing them | |
SE9904505D0 (sv) | Novel compounds | |
NO20032801L (no) | Tiazolderivater for behandling av PPAR-relaterte forstyrrelser | |
BG66085B1 (bg) | Фенилаланинови производни | |
NO20011721D0 (no) | N-aralkylaminotetraliner som ligander for neuropeptid Y Y5 reseptor | |
NO20020282D0 (no) | Nytt difenylpiperidinderivat | |
SE0102440D0 (sv) | New compound | |
IL152337A0 (en) | A pyridine-1-oxide derivative, and process for its transformation into pharmaceutically effective compounds | |
ATE319473T1 (de) | Melagatran zur behandlung von entzündungen | |
DE60128100D1 (de) | Analgetisches arzneimittel | |
GB9907571D0 (en) | Compounds | |
DE69819539D1 (de) | Antithrombotische mittel | |
NO20014889L (no) | Fremgangsmåte for fremstilling av medisinske midler | |
EP1027051A4 (en) | ANTITHROMBOTIC AGENTS | |
SE0004827D0 (sv) | Therapeutic compounds | |
SE9901338D0 (sv) | Novel process | |
AU1434201A (en) | Antithrombotic agents | |
ATE268768T1 (de) | Antithrombosemittel | |
SE9803277D0 (sv) | Novel compounds | |
NO20016281D0 (no) | Fremgangsmåte for fremstilling av legemiddel- mellomproduktforbindelser | |
MX9606264A (es) | Compuestos de 1-fenil-2-dimetilaminometil-ciclohexan-1-ol como sustancias farmacologicas activas. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |